TWD 571.0
(-2.89%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 38.93 Million TWD | 203.68% |
2022 | 12.82 Million TWD | 3.9% |
2021 | 12.33 Million TWD | 19.22% |
2020 | 10.35 Million TWD | -44.5% |
2019 | 18.65 Million TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 7.84 Million TWD | 97.88% |
2024 Q1 | 3.96 Million TWD | -66.53% |
2023 Q2 | 11.52 Million TWD | 211.32% |
2023 FY | 38.93 Million TWD | 203.68% |
2023 Q3 | 11.85 Million TWD | 2.8% |
2023 Q4 | 11.85 Million TWD | 0.0% |
2023 Q1 | 3.7 Million TWD | -41.9% |
2022 FY | 12.82 Million TWD | 3.9% |
2022 Q4 | 6.37 Million TWD | 0.0% |
2022 Q3 | 6.37 Million TWD | 0.0% |
2021 FY | 12.33 Million TWD | 19.22% |
2020 FY | 10.35 Million TWD | -44.5% |
2019 FY | 18.65 Million TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | -5247.802% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 96.507% |
Level Biotechnology Inc. | 660.61 Million TWD | 94.107% |
Sagittarius Life Science Corp | 440.46 Million TWD | 91.161% |
NeoCore Technology Co., Ltd. | 64.72 Million TWD | 39.854% |
TaiMed Biologics Inc. | 491.77 Million TWD | 92.083% |
GlycoNex Incorporation | 2.54 Million TWD | -1431.55% |
VBI | 55.85 Million TWD | 30.296% |
GeneReach Biotechnology Corp. | 225.46 Million TWD | 82.732% |
Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | 87.679% |
SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | -92.771% |
Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | 90.172% |
Visgeneer Inc. | 147.99 Million TWD | 73.694% |
Mycenax Biotech Inc. | 652.62 Million TWD | 94.035% |
Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 97.695% |
G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | 78.543% |
Neith Corporation | 39.9 Million TWD | 2.433% |
Medigen Vaccine Biologics Corporation | 389.62 Million TWD | 90.008% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -71.19% |
Enimmune corporation | 43.49 Million TWD | 10.489% |
TaiRx, Inc. | 5.08 Million TWD | -666.076% |
CHO Pharma, Inc. | - TWD | -Infinity% |
EirGenix Inc. | 1.02 Billion TWD | 96.193% |
BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | 85.293% |
Sunny Pharmtech Inc. | 428.82 Million TWD | 90.921% |
Lin BioScience, Inc. | - TWD | -Infinity% |
BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | 64.578% |
Feng Chi Biotech Corp. | 180.57 Million TWD | 78.44% |
Bio Preventive Medicine Corp. | 1.2 Million TWD | -3122.848% |
Lukas Biomedical Inc. | 231.83 Million TWD | 83.207% |
RBC Bioscience Corporation | 172.46 Million TWD | 77.426% |
BiOptic Inc. | 228.26 Million TWD | 82.945% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -43157.778% |
Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | -308.778% |
Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | -702.722% |
Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 97.881% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
NaviFUS Corp. | 22.48 Million TWD | -73.177% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | 72.423% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | -4736.273% |
Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | 95.137% |
Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | 31.597% |
AP Biosciences Inc | 32.25 Million TWD | -20.708% |
Medigen Biotechnology Corp. | 1.15 Billion TWD | 96.637% |
3D Global Biotech Inc. | 20.63 Million TWD | -88.688% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 87.621% |
Intech Biopharm Corporation | 25.84 Million TWD | -50.625% |
Oneness Biotech Co., Ltd. | 86.78 Million TWD | 55.139% |
Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
TWi Biotechnology, Inc. | - TWD | -Infinity% |
Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | 94.867% |
TCI GENE Inc. | 333.85 Million TWD | 88.339% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -216188.889% |
Senhwa Biosciences, Inc. | 1 Million TWD | -3793.2% |
Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | 54.45% |
NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | 75.689% |
PharmaEngine, Inc. | 767.66 Million TWD | 94.929% |
Savior Lifetec Corporation | 1.05 Billion TWD | 96.293% |
TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | 68.382% |
OBI Pharma, Inc. | 41.54 Million TWD | 6.299% |
Meribank Biotech Co., Ltd | 234.34 Million TWD | 83.387% |
Acepodia, Inc. | 16.59 Million TWD | -134.629% |